The Stem Cell Hard Sell: Report from a Clinic's Patient Recruitment Seminar

The growing direct‐to‐consumer, stem cell clinic industry in the U.S. uses a number of strategies for patient recruitment, including self‐styled educational seminars, which may reach thousands of members of the public annually. Here I report on a first‐hand experience at such a seminar that I recent...

Descripción completa

Detalles Bibliográficos
Autor principal: Knoepfler, Paul S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442738/
https://www.ncbi.nlm.nih.gov/pubmed/28170181
http://dx.doi.org/10.5966/sctm.2016-0208
_version_ 1783238456528338944
author Knoepfler, Paul S.
author_facet Knoepfler, Paul S.
author_sort Knoepfler, Paul S.
collection PubMed
description The growing direct‐to‐consumer, stem cell clinic industry in the U.S. uses a number of strategies for patient recruitment, including self‐styled educational seminars, which may reach thousands of members of the public annually. Here I report on a first‐hand experience at such a seminar that I recently attended. Numerous specific medical claims were made at the seminar: no potential for rejection; no side effects, including no pain; proven efficacy for a variety of conditions, including in particular arthritis and pain; and U.S. Food and Drug Administration approval. I discuss the potential impact of these kinds of seminars on the public and on the stem cell field. Stem Cells Translational Medicine 2017;6:14–16
format Online
Article
Text
id pubmed-5442738
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-54427382017-06-15 The Stem Cell Hard Sell: Report from a Clinic's Patient Recruitment Seminar Knoepfler, Paul S. Stem Cells Transl Med Perspectives The growing direct‐to‐consumer, stem cell clinic industry in the U.S. uses a number of strategies for patient recruitment, including self‐styled educational seminars, which may reach thousands of members of the public annually. Here I report on a first‐hand experience at such a seminar that I recently attended. Numerous specific medical claims were made at the seminar: no potential for rejection; no side effects, including no pain; proven efficacy for a variety of conditions, including in particular arthritis and pain; and U.S. Food and Drug Administration approval. I discuss the potential impact of these kinds of seminars on the public and on the stem cell field. Stem Cells Translational Medicine 2017;6:14–16 John Wiley and Sons Inc. 2016-08-02 2017-01 /pmc/articles/PMC5442738/ /pubmed/28170181 http://dx.doi.org/10.5966/sctm.2016-0208 Text en © 2016 The Authors Stem Cells Translational Medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Perspectives
Knoepfler, Paul S.
The Stem Cell Hard Sell: Report from a Clinic's Patient Recruitment Seminar
title The Stem Cell Hard Sell: Report from a Clinic's Patient Recruitment Seminar
title_full The Stem Cell Hard Sell: Report from a Clinic's Patient Recruitment Seminar
title_fullStr The Stem Cell Hard Sell: Report from a Clinic's Patient Recruitment Seminar
title_full_unstemmed The Stem Cell Hard Sell: Report from a Clinic's Patient Recruitment Seminar
title_short The Stem Cell Hard Sell: Report from a Clinic's Patient Recruitment Seminar
title_sort stem cell hard sell: report from a clinic's patient recruitment seminar
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442738/
https://www.ncbi.nlm.nih.gov/pubmed/28170181
http://dx.doi.org/10.5966/sctm.2016-0208
work_keys_str_mv AT knoepflerpauls thestemcellhardsellreportfromaclinicspatientrecruitmentseminar
AT knoepflerpauls stemcellhardsellreportfromaclinicspatientrecruitmentseminar

Ejemplares similares